DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Pyelonephritis and urosepsis

Essential points for quick revision.

!
Obstructed infected urinary tract

Sepsis with hydronephrosis, an obstructing stone, anuria or a solitary obstructed kidney can deteriorate despite antibiotics and requires emergency decompression.

Action: Use ABCDE, obtain urine and blood cultures without delaying antimicrobials, give physiology-guided intravenous crystalloid and involve urology immediately for ureteric stenting or nephrostomy.

Synopsis

Recognise renal parenchymal infection and urinary sepsis, obtain cultures, select tissue-active treatment and secure urgent drainage when obstruction makes antibiotics insufficient.

  • Pyelonephritis causes fever, flank or loin pain, systemic upset and urinary symptoms, although lower urinary symptoms may be absent.
  • Send a midstream urine culture before antibiotics in every suspected acute pyelonephritis case when this does not delay treatment.
  • Assess for sepsis and obstruction at presentation; an infected blocked system needs drainage as well as antimicrobial therapy.

Key red flags

Hypotension, tachypnoea, confusion, mottling, rising lactate or oliguria indicates urinary sepsis.

Renal infection syndrome

Fever, rigors, loin or flank pain, costovertebral-angle tenderness, nausea and vomiting support pyelonephritis, with or without dysuria and frequency.

Investigation priorities

01
Midstream urine culture and susceptibilityFirst step

Confirm the urinary organism and allow directed antimicrobial treatment.

Management branches

SEPSISResuscitate and treat immediately

Pyelonephritis is accompanied by organ dysfunction, shock, severe vomiting or inability to take oral treatment.

  1. Use ABCDE, measure glucose and lactate, establish access, monitor urine output and give oxygen and intravenous crystalloid according to physiology.
  2. Obtain urine and blood cultures promptly and start a locally recommended intravenous regimen adjusted for allergy, renal function and previous resistant isolates.
OUTPATIENTUse oral treatment selectively

A non-pregnant adult is stable, can take fluids and medicine and has no immediate complication concern.

Key medicines

Cefalexin oral regimenGive 500 mg orally twice or three times daily for seven to ten days, using higher severe-infection dosing only within current guidance.
Co-amoxiclav oral regimenGive 625 mg orally three times daily for seven to ten days only when urine culture confirms susceptibility.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom